MENLO PARK, Calif.,
Nov. 10, 2015 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX) will nearly double
its national retail footprint for the company's breast health
supplement, Violet® iodine, when it will become available in 3,025
GNC store locations in the United
States next month.
Violet iodine, a first-of-its-kind breast health supplement for
women, relieves the painful symptoms of monthly breast discomfort
and dense, fibrous breast tissue. It is currently available for
purchase at select CVS Pharmacy locations, the Vitamin Shoppe,
Harris Teeter grocery stores, and
online at drugstore.com, and walgreens.com.
"GNC is a leading global specialty retailer of health and
wellness products and is devoted to helping its customers improve
the quality of their lives," said Anja
Krammer, president and co-founder of BioPharmX Corporation.
"By putting Violet on its shelves, GNC is empowering women to
proactively manage their own breast health and allows us to
continue our journey in making breast health solutions available to
as many women as possible."
Availability of Violet iodine at GNC is expected to begin in
mid-December.
For more information on Violet iodine, please visit
www.violetdaily.com.
About BioPharmX™ Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company, which seeks to provide products through proprietary
platform technologies for prescription, over-the-counter ("OTC"),
and supplement applications in the health and wellness markets,
including women's health and dermatology. To learn more about
BioPharmX, visit www.BioPharmX.com.
Forward-Looking Statements
The information in this
press release contains forward-looking statements and information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, or the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended, or the Exchange Act, which are
subject to the "safe harbor" created by those section.
This press release contains forward-looking statements about the
company's expectations, plans, intentions, and strategies,
including, but not limited to, statements regarding, including with
respect to: the success of the commercialization of VI2OLET iodine,
the effectiveness of BPX01, the timing with respect to filing an
IND and clinical trials for BPX01, the release of key data for
BPX01, the release of key data and the successful completion of
multi-site IRB studies for BPX03 and the successful completion of
the private placement with Korea Investment Partners Overseas
Expansion Platform Fund. These forward-looking statements may be
identified by words such as "plan," "expect," "anticipate,"
"believe," or similar expressions that are intended to identify
such forward-looking statements. These forward-looking
statements involve risks and uncertainties, as well as assumptions,
which, if they do not fully materialize or prove incorrect, could
cause our results to differ materially from those expressed or
implied by such forward-looking statements. The risks and
uncertainties include those described in the company's filings with
the Securities and Exchange Commission. Given these risks and
uncertainties, you are cautioned not to place undue reliance on
such forward-looking statements. The forward-looking
statements included in this news release are made only as of the
date hereof and the company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required under applicable securities law.
Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-corporation-to-offer-violet-iodine-supplement-in-over-3000-general-nutrition-center-gnc-stores-300175527.html
SOURCE BioPharmX Corporation